“Intellego has undergone a major corporate governance cleanup, which was validated by a favorable, immaterial financial audit adjustment by Deloitte. The company's patented UV dosimeter indicator technology operates on an asset-light, high-margin recurring consumable model that is seeing strong commercial adoption in healthcare and industrial curing sectors.”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.